Delivery Order SPE2DB24D1104-SPE2DB24FXUW8
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and federal contractor. The $2,086.06 firm-fixed-price contract is for the supply of 120 tablets of Alfuzosin HCL ER 10 mg, a medication used to treat benign prostatic hyperplasia. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.97 firm fixed-price delivery order is for the supply of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
- This federal contract award, valued at $2,092.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of 4566317084 - Alfuzosin HCL ER 10 mg Tablets, in quantities of 120 per bottle. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,345.79 firm fixed price delivery order is for the supply of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. This award is considered a "child" contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.29 firm fixed price delivery order is for 90 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award, valued at $5,436.87, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets, a pharmaceutical product, and has a performance period through May 15, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,900.24, is for the supply of Alfuzosin HCl ER 10 mg Tablets 120s, a medication used to treat symptoms of an enlarged prostate gland. The contract is a firm-fixed-price delivery order with a period of performance through May 16, 2024. This award is part of a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,329.88, is a delivery order for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has an ultimate completion date of March 26, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,881.57, is for the supply of Alfuzosin HCl ER 10 mg tablets. The contract is a firm fixed-price, non-set-aside delivery order that is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,018.77, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB24FXUW8Delivery Order
This federal contract award, valued at $5,603.19, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 3/1/24 |